Summary
The concentration of iron was determined by atomic absorption spectroscopy in post-mortem tissue from various brain regions in schizophrenic patients and control subjects without neuropsychiatric diseases. Analysis of iron content showed a clear regional difference with highest iron levels in the caudate nucleus. There was no correlation between iron content and the neuroleptic-free period prior to death. Iron content in the schizophrenic group was not different from controls for the cortex, gyrus cinguli, caudate nucleus, hippocampus, amygdala, corpus mamillare and hypothalamus. In one patient who had suffered from tardive dyskinesia prior to death, the iron concentration in all the brain regions examined was within the mean ± 2 SD range of those schizophrenic subjects without prior tardive dyskinesia. The present results suggest that there are no profound differences in the content of iron in post-mortem brain tissue of schizophrenic and control subjects.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Bartzokis G, Garber HJ, Marder SR, Olendorf WH (1990) MRI in tardive dyskinesia: shortened left caudate T2. Biol Psychiatry 28: 1027–1036
Campbell WG, Raskind MA, Gordon T, Shaw CM (1985) Iron pigment in the brain of a man with tardive dyskinesia. Am J Psychiatry 142: 364–365
Casanova MF, Waldman IN, Kleinman JE (1990) A postmortem quantitative study of iron in the globus pallidus of schizophrenic patients. Biol Psychiatry 27: 143–149
Casanova ME, Comparini SO, Kim RW, Kleinman JE (1992) Staining intensity of brain iron in patients with schizophrenia: a postmortem study. J Neuropsychiatr Clin Neurosci 4: 36–41
Feighner JP, Robins E, Guze SB, Woodruff RA, Winokur G, Munoz R (1972) Diagnostic criteria for use in psychiatric research. Arch Gen Psychiatry 26: 57–63
Hallgren B, Sourander P (1958) The effect of age on the non-haemin iron in the human brain. J Neurochem 3: 41–51
Harrison WW, Netsky MG, Brown MD (1968) Trace elements in human brain: copper, zinc, iron, and magnesium. Clin Chim Acta 21: 55–60
Hill JM (1988) The distribution of iron in the brain. In: Youdim MBH (ed) Brain iron: neurochemistry and behavioural aspects. Taylor and Francis, London, pp 1–24
Hill JM, Switzer RC (1984) The regional distribution and cellular localization of iron in the rat brain. Neuroscience 11: 595–603
Hopf A (1952) Über histopathologische Veränderungen im Pallidum und Striatum bei Schizophrenie. In: First International Congress of Neuropathology, vol 3. Rosenberg and Sellier, Turin, pp 629–635
Hunter R, Blackwood W, Smith MC, Cumings JN (1968) Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication. J Neurol Sci 7: 263–273
Josephy H (1930) Dementia praecox (Schizophrenie). In: Bumke O (Hrsg) Die Anatomie der Psychosen. Springer, Berlin
Kornhuber J, Lange KW, Kruzik P, Jellinger K, Gabriel E, Riederer P (1993) The contents of iron, copper, zinc, magnesium, and calcium in post-mortem brain tissue from schizophrenic patients. Biol Psychiatry (submitted)
Lange KW, Youdim MBH, Riederer P (1992) Neurotoxicity and neuroprotection in Parkinson’s disease. J Neural Transm [Suppl] 38: 27–44
Löwenthal A, Bruyn GW (1968) Calcification of the striopallidodentate system. In: Vinken PJ, Bruyn GW (eds) Handbook of clinical neurology, vol 6. North-Holland, Amsterdam, pp 703–725
Pollitt E, Leibel R (eds) (1982) Iron deficiency: brain biochemistry and behaviour. Raven Press, New York
Potkin SG, Shore D, Torrey EF, Weinberger DR, Gillin JC, Henkin RI, Agarwal RP, Wyatt RJ (1982) Cerebrospinal fluid zinc concentrations in ex-heroin addicts and patients with schizophrenia: some preliminary observations. Biol Psychiatry 17: 1315–1322
Riederer P, Sofic E, Rausch WD, Schmidt B, Reynolds GP, Jellinger K, Youdim MBH (1989) Transition metals, ferritin, glutathione, and ascorbic acid in parkinsonian brains. J Neurochem 52: 515–520
Spatz H (1924) Über den Eisennachweis im Gehirn, besonders in Zentren des extrapyramidal-motorischen Systems. Z Neurol Psychiat LXXVII: 261–390
Schiffer D (1971) Calcification in the nervous tissue. In: Minkler J (ed) Pathology of the nervous system, vol 3. McGraw-Hill, New York, pp 1342–1360
Smeyers-Verbeke J, Michotte Y, Pelsmaeckers J, et al (1975) The chemical composition of idiopathic nonarteriosclerotic cerebral calcifications. Neurology 25: 48–57
Stevens BJ (1970) Clinical applications of atomic absorption spectroscopy. Varian Techtron Pty Ltd, Australia
Stevens JR (1982) Neuropathology of schizophrenia. Arch Gen Psychiatry 39: 1131–1139
Weiner WJ, Nausieda PA, Klawans HL (1977) Effect of chlorpromazine on central nervous system concentrations of manganese, iron, and copper. Life Sci 20: 1181–1186
Wilcoxon F (1945) Individual comparisons by ranking methods. Biometrics 1: 80–83
Yehuda S, Youdim MBH (1988) Brain iron deficiency: biochemistry and behaviour. In: Youdim MBH (ed) Brain iron: neurochemical and behavioural aspects. Taylor and Francis, London, pp 89–114
Youdim MBH (1988) Brain iron: neurochemical and behavioural aspects. Taylor and Francis, London
Youdim MBH (1990) Developmental neuropharmacological and biochemical aspects of iron-deficiency. In: Dobbing J (ed) Brain, behaviour and iron-deficiency. Springer, Berlin Heidelberg New York Tokyo
Youdim MBH, Ben-Shachar D, Riederer P (1989) Is Parkinson’s disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration? Acta Neurol Scand 26: 47–54
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag/Wien
About this paper
Cite this paper
Lange, K.W. et al. (1993). Brain iron and schizophrenia. In: Riederer, P., Youdim, M.B.H. (eds) Iron in Central Nervous System Disorders. Key Topics in Brain Research. Springer, Vienna. https://doi.org/10.1007/978-3-7091-9322-8_3
Download citation
DOI: https://doi.org/10.1007/978-3-7091-9322-8_3
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82520-4
Online ISBN: 978-3-7091-9322-8
eBook Packages: Springer Book Archive